LitCovid-sample-Enju  

PMC:7199903 / 419-735 JSONTXT 12 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T63 2-10 NN denotes antibody
T64 11-25 NN denotes neutralization
T65 27-35 NNP denotes Watanabe
T66 36-38 FW denotes et
T67 39-42 FW denotes al.
T68 43-52 VBN denotes expressed
T69 53-56 CC denotes and
T70 57-65 VBN denotes purified
T71 66-77 JJ denotes recombinant
T72 78-90 VBN denotes glycosylated
T73 91-96 NN denotes spike
T74 97-104 NNS denotes trimers
T75 104-105 -COMMA- denotes ,
T76 106-117 VBD denotes proteolysed
T77 118-122 PRP denotes them
T78 123-125 TO denotes to
T79 126-131 VB denotes yield
T80 132-145 NNS denotes glycopeptides
T81 146-156 VBG denotes containing
T82 157-158 DT denotes a
T83 159-165 JJ denotes single
T84 166-172 NN denotes glycan
T85 172-173 -COMMA- denotes ,
T86 174-177 CC denotes and
T87 178-188 VBD denotes determined
T88 189-192 DT denotes the
T89 193-204 NN denotes composition
T90 205-207 IN denotes of
T91 208-211 DT denotes the
T92 212-218 NN denotes glycan
T93 219-224 NNS denotes sites
T94 225-227 IN denotes by
T95 228-232 NN denotes mass
T96 233-245 NN denotes spectrometry
T97 247-250 DT denotes The
T98 251-259 NN denotes analysis
T99 260-268 VBZ denotes provides
T100 269-270 DT denotes a
T101 271-280 NN denotes benchmark
T102 281-285 WDT denotes that
T103 286-289 MD denotes can
T104 290-292 VB denotes be
T105 293-297 VBN denotes used
T106 298-300 TO denotes to
T107 301-308 VB denotes measure
T108 309-316 NN denotes antigen
R100 T98 T97 arg1Of analysis,The
R101 T98 T99 arg1Of analysis,provides
R102 T101 T99 arg2Of benchmark,provides
R103 T101 T100 arg1Of benchmark,a
R104 T101 T102 arg1Of benchmark,that
R105 T101 T103 arg1Of benchmark,can
R106 T105 T103 arg2Of used,can
R107 T101 T104 arg1Of benchmark,be
R108 T105 T104 arg2Of used,be
R109 T101 T105 arg2Of benchmark,used
R110 T107 T105 arg3Of measure,used
R111 T107 T106 arg1Of measure,to
R112 T101 T107 arg1Of benchmark,measure
R65 T64 T63 arg1Of neutralization,antibody
R66 T74 T65 arg1Of trimers,Watanabe
R67 T67 T66 arg1Of al.,et
R68 T65 T67 arg1Of Watanabe,al.
R69 T67 T68 arg2Of al.,expressed
R70 T68 T69 arg1Of expressed,and
R71 T70 T69 arg2Of purified,and
R72 T67 T70 arg2Of al.,purified
R73 T74 T71 arg1Of trimers,recombinant
R74 T74 T72 arg2Of trimers,glycosylated
R75 T74 T73 arg1Of trimers,spike
R76 T86 T75 arg1Of and,","
R77 T74 T76 arg1Of trimers,proteolysed
R78 T77 T76 arg2Of them,proteolysed
R79 T79 T76 arg3Of yield,proteolysed
R80 T79 T78 arg1Of yield,to
R81 T77 T79 arg1Of them,yield
R82 T80 T79 arg2Of glycopeptides,yield
R83 T80 T81 arg1Of glycopeptides,containing
R84 T84 T81 arg2Of glycan,containing
R85 T84 T82 arg1Of glycan,a
R86 T84 T83 arg1Of glycan,single
R87 T86 T85 arg1Of and,","
R88 T76 T86 arg1Of proteolysed,and
R89 T87 T86 arg2Of determined,and
R90 T74 T87 arg1Of trimers,determined
R91 T89 T87 arg2Of composition,determined
R92 T89 T88 arg1Of composition,the
R93 T89 T90 arg1Of composition,of
R94 T93 T90 arg2Of sites,of
R95 T93 T91 arg1Of sites,the
R96 T93 T92 arg1Of sites,glycan
R97 T89 T94 arg1Of composition,by
R98 T96 T94 arg2Of spectrometry,by
R99 T96 T95 arg1Of spectrometry,mass